India to Netherlands: Fluticasone Export Trade Route
India has recorded 537 verified shipments of Fluticasone exported to Netherlands, representing a combined trade value of $69.4M USD. This corridor is served by 5 active Indian exporters, with an average shipment value of $129.3K USD. The leading Indian exporter is CIPLA LIMITED, which accounts for 100% of total export value with 526 shipments worth $69.4M USD. On the buying side, Mylan Ireland Ltd is the largest importer in Netherlands with $26.7M USD in purchases. The top 3 suppliers — CIPLA LIMITED, TULSI MEDICAL & GENERAL STORES , ALPHA-PHARMA HEALTHCARE PRIVATE LIMITED — together control 100% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Netherlands Fluticasone corridor is one of India's established pharmaceutical export routes, with 537 shipments documented worth a combined $69.4M USD. The route is dominated by CIPLA LIMITED, which alone accounts for roughly 100% of all export value, reflecting the consolidated nature of India's fluticasone manufacturing sector.
Across 5 active suppliers, the average shipment value stands at $129.3K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 83% of all shipments, consistent with fluticasone's non-urgent bulk-order profile.
Shipment activity peaks during July–September, with an average transit time of 24 days port-to-port. The route has recorded an annual growth rate of 23.8%, placing it at rank #9 among India's top fluticasone export destinations globally.
On the import side, key buyers of Indian fluticasone in Netherlands include Mylan Ireland Ltd, MYLAN IRELAND LTD, MYLAN IRELAND LIMITED and 11 others. Mylan Ireland Ltd is the single largest importer with 152 shipments valued at $26.7M USD.
Route Characteristics
- Average transit24 days
- Peak seasonQ3
- Primary modeSea freight
- Top portSAHAR AIR
Market Position
- Global rank#9
- Annual growth+23.8%
- Demand growth+20.1%
- Regulatory ease87/100
Top 10 Indian Fluticasone Exporters to Netherlands
Showing top 10 of 5 Indian suppliers exporting Fluticasone to Netherlands, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | CIPLA LIMITED Avg $132.0K per shipment | 526 | $69.4M | 100.0% |
| 2 | TULSI MEDICAL & GENERAL STORES Avg $28 per shipment | 4 | $110 | 0.0% |
| 3 | ALPHA-PHARMA HEALTHCARE PRIVATE LIMITED Avg $30 per shipment | 3 | $91 | 0.0% |
| 4 | TULSI MEDICAL GENERAL STORES Avg $45 per shipment | 2 | $90 | 0.0% |
| 5 | TULSI MEDICAL & GENERAL STORES Avg $36 per shipment | 2 | $71 | 0.0% |
This table shows the top 10 of 5 Indian companies exporting fluticasone to Netherlands, ranked by total trade value. The listed exporters are: CIPLA LIMITED, TULSI MEDICAL & GENERAL STORES , ALPHA-PHARMA HEALTHCARE PRIVATE LIMITED, TULSI MEDICAL GENERAL STORES, TULSI MEDICAL & GENERAL STORES. CIPLA LIMITED is the dominant supplier with 526 shipments worth $69.4M USD, giving it a 100% market share. The top 3 suppliers together account for 100% of the total trade value on this route.
Top 10 Fluticasone Importers in Netherlands
Showing top 10 of 14 known buyers in Netherlands receiving Fluticasone shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian fluticasone in Netherlands include Mylan Ireland Ltd, MYLAN IRELAND LTD, MYLAN IRELAND LIMITED, Mylan Ireland LIMITED, MYLAN IRELAND LTD,,, among 14 total buyers. The largest importer is Mylan Ireland Ltd, accounting for $26.7M USD across 152 shipments — representing 39% of all fluticasone imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | Mylan Ireland Ltd | 152 | $26.7M | 38.5% |
| 2 | MYLAN IRELAND LTD | 197 | $23.2M | 33.5% |
| 3 | MYLAN IRELAND LIMITED | 109 | $12.4M | 17.8% |
| 4 | Mylan Ireland LIMITED | 27 | $4.5M | 6.5% |
| 5 | MYLAN IRELAND LTD,, | 9 | $1.6M | 2.3% |
| 6 | CONSIGNMENT STOCK OF S D PHARMA CZ PHARMOS ASTHEODOR | 16 | $539.7K | 0.8% |
| 7 | CONSIGNMENT STOCK OF S&D PHARMA CZ | 16 | $464.6K | 0.7% |
| 8 | SPRING/POSTNL | 3 | $91 | 0.0% |
| 9 | Master & Owner Of SFL OTTAWA | 3 | $73 | 0.0% |
| 10 | Consignee Master Owner Of STRENGT | 1 | $49 | 0.0% |
Showing top 10 of 14 Fluticasone importers in Netherlands on this route.
Top 10 Fluticasone Formulations Imported by Netherlands
Showing top 10 of 105 product formulations shipped on the India to Netherlands Fluticasone route, ranked by trade value
Netherlands imports a wide range of fluticasone formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — DYMISTA (AZELASTINE HYDROCHLORIDE 137MCG+FLUTICASONE PROPIONATE 50MCG(PER SPRAY)NASAL SUSPENSION);Dymista trade pack - — accounts for $7.9M USD across 46 shipments. There are 105 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | DYMISTA (AZELASTINE HYDROCHLORIDE 137MCG+FLUTICASONE PROPIONATE 50MCG(PER SPRAY)NASAL SUSPENSION);Dymista trade pack - | 46 | $7.9M | 11.5% |
| 2 | DYMISTA AZELASTINE HYDROCHLORIDE 137MCG+FLUTICASONE PROPIONATE 50MCG PER SPRAY NASAL SUSPENSION;Dymista trade pack - | 41 | $7.7M | 11.1% |
| 3 | DYMISTA (AZELASTINE HYDROCHLORIDE 137MCG+FLUTICASONE PROPIONATE 50MCG (PER SPRAY) NASAL SUSPENSION);Dymista trade pack - | 44 | $7.4M | 10.7% |
| 4 | DYMISTA (AZELASTINE HYDROCHLORIDE 137MCG+FLUTICASONE PROPIONATE 50MCG (PER SPRAY) NASAL SUSPENSION);DYMISTA TRADE PACK - | 46 | $5.3M | 7.6% |
| 5 | DYMISTA AZELASTINE HCL 137MCG FLUTICASONE PROPIONATE 50MCG PER SPRAY NASAL SUSPENSION 17ml 120spray P S 1X120 MD | 32 | $4.7M | 6.8% |
| 6 | DYMISTA (AZELASTINE HYDROCHLORIDE 137MCG+FLUTICASONE PROPIONATE 50MCG (PER SPRAY) NASAL SUSPENSION);DYMISTA TRADE PACK -NOS | 87 | $4.5M | 6.4% |
| 7 | DYMISTA NDA MEDA - GR TRADE PACK AZELASTINE HYDROCHLORIDE 137MCG+FLUTICASONE PROPIONATE 50MCGPER SPRAY NASAL SU | 12 | $2.2M | 3.2% |
| 8 | DYMISTA AZELASTINE HYDROCHLORIDE 137MCG+ FLUTICASONE PROPIONATE 50 MCG PER SPRAY NASAL SUSPENSION;Dymista trade pac | 7 | $1.4M | 2.0% |
| 9 | DYMISTA TRADE PACK AZELASTINE HYDROCHLORIDE 137 MCG AND FLUTICASONE PROPIONATE50 MCG NASAL SUSPENSION -PT - 400545278 | 7 | $1.4M | 2.0% |
| 10 | DYMISTA (AZELASTINE HYDROCHLORIDE 137MCG+FLUTICASONE PROPIONATE 50MCG(PER SPRAY)NASAL SUSPENSION);Dymista trade pack - 1 | 7 | $1.2M | 1.7% |
Showing top 10 of 105 Fluticasone formulations imported by Netherlands on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 83%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
SAHAR AIR handles the highest volume with 298 shipments. Transit time averages 24 days by sea.
Market Dynamics
India's fluticasone exports to Netherlands are driven primarily by a handful of large-scale manufacturers. CIPLA LIMITED with 526 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 5 active exporters signals a competitive but concentrated market — buyers in Netherlands benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — CIPLA LIMITED, TULSI MEDICAL & GENERAL STORES , ALPHA-PHARMA HEALTHCARE PRIVATE LIMITED — together account for 100% of total trade value on this route. The average shipment value of $129.3K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.
Beyond the primary product category, shipments on this route include closely related formulations such as dymista azelastine hydrochloride 137mcg+fluticasone propionate 50mcg per spray nasal suspension;dymista trade pack - and dymista (azelastine hydrochloride 137mcg+fluticasone propionate 50mcg (per spray) nasal suspension);dymista trade pack -, suggesting that buyers in Netherlands tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, Mylan Ireland Ltd is the largest importer with 152 shipments worth $26.7M USD — representing 39% of all fluticasone imports from India on this route. A total of 14 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $69.4M
- Avg. Shipment
- $129.3K
- Suppliers
- 5
- Buyers
- 14
- Transit (Sea)
- ~24 days
- Annual Growth
- +23.8%
Related Analysis
Reverse Direction
Netherlands → India — Fluticasone (Import)Other Fluticasone Routes
Fluticasone — Export Intelligence Video
Visual overview of India's fluticasone India to Netherlands export trade route — top suppliers, destinations, pricing, and trade routes
Unlock the Full India to Netherlands Fluticasone Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 537 shipments on this route.
Frequently Asked Questions — India to Netherlands Fluticasone Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Fluticasone to Netherlands?
The leading Indian exporters of Fluticasone to Netherlands are CIPLA LIMITED, TULSI MEDICAL & GENERAL STORES , ALPHA-PHARMA HEALTHCARE PRIVATE LIMITED. CIPLA LIMITED holds the largest market share at approximately 100% of total trade value on this route.
Q What is the total value of Fluticasone exports from India to Netherlands?
India exports Fluticasone to Netherlands worth approximately $69.4M USD across 537 recorded shipments. The average value per shipment is $129.3K USD.
Q Which ports does India use to ship Fluticasone to Netherlands?
The most active port of origin is SAHAR AIR with 298 shipments. Indian exporters primarily use sea freight for this route, with 83% of shipments going by sea and 28% by air.
Q How long does shipping take from India to Netherlands for Fluticasone?
The average transit time for Fluticasone shipments from India to Netherlands is approximately 24 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during July–September.
Q Is the India to Netherlands Fluticasone trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 23.8% with demand growth tracking at 20.1%. The route is ranked #9 among India's top Fluticasone export destinations globally.
Q How many suppliers are active on the India to Netherlands Fluticasone route?
There are currently 5 active Indian suppliers exporting Fluticasone to Netherlands. The market is moderately concentrated with CIPLA LIMITED accounting for 100% of total shipment value.
Q Who are the main importers of Fluticasone from India in Netherlands?
The leading importers of Indian Fluticasone in Netherlands include Mylan Ireland Ltd, MYLAN IRELAND LTD, MYLAN IRELAND LIMITED, Mylan Ireland LIMITED, MYLAN IRELAND LTD,,. Mylan Ireland Ltd is the largest buyer with 152 shipments worth $26.7M USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to Netherlands export trade corridor identified from Indian Customs (DGFT) records for Fluticasone.
- 2.Supplier/Buyer Matching: 5 Indian exporters and 14 importers in Netherlands matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 537 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
537 Verified Shipments
5 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists